BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Johnson Outdoors
JOUT
$510M
| $20K | ﹤0.01% |
220
-1,365
| -86% | -$97.6K |
|
|
EIDX
3252
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $20K | ﹤0.01% |
419
-3,072
| -88% | -$143K |
|
3253
Motorcar Parts of America
MPAA
$236M
| $19.9K | ﹤0.01% |
1,129
-6,361
| -85% | -$89.8K |
|
3254
Replimune Group
REPL
$1.43B
| $19.9K | ﹤0.01% |
800
-3,271
| -80% | -$57.9K |
|
|
WSR
3255
DELISTED
Whitestone REIT
WSR
| $19.8K | ﹤0.01% |
2,725
-12,745
| -82% | -$81K |
|
3256
Lee Enterprises
LEE
$183M
| $19.8K | ﹤0.01% |
2,017
+369
| +22% | +$3.53K |
|
|
FLIC
3257
DELISTED
First of Long Island Corp
FLIC
| $19.7K | ﹤0.01% |
1,206
-5,997
| -83% | -$91.9K |
|
3258
AdvanSix
ASIX
$457M
| $19.7K | ﹤0.01% |
1,678
-9,464
| -85% | -$110K |
|
|
FBMS
3259
DELISTED
The First Bancshares, Inc.
FBMS
| $19.7K | ﹤0.01% |
874
-4,264
| -83% | -$86.6K |
|
3260
Chefs' Warehouse
CHEF
$4.6B
| $19.7K | ﹤0.01% |
1,448
-8,378
| -85% | -$116K |
|
|
CIO
3261
DELISTED
City Office REIT
CIO
| $19.6K | ﹤0.01% |
1,950
-14,561
| -88% | -$135K |
|
3262
Cooper-Standard Automotive
CPS
$500M
| $19.6K | ﹤0.01% |
1,479
-5,592
| -79% | -$67.8K |
|
3263
KB Financial Group
KB
$42.1B
| $19.6K | ﹤0.01% |
704
+201
| +40% | +$5.49K |
|
3264
Digi International
DGII
$3.19B
| $19.6K | ﹤0.01% |
1,681
-9,510
| -85% | -$102K |
|
3265
OrthoPediatrics
KIDS
$648M
| $19.6K | ﹤0.01% |
447
-2,603
| -85% | -$117K |
|
|
ATRS
3266
DELISTED
Antares Pharma, Inc.
ATRS
| $19.5K | ﹤0.01% |
7,106
-317,990
| -98% | -$887K |
|
3267
Impinj
PI
$5.28B
| $19.5K | ﹤0.01% |
709
-4,489
| -86% | -$105K |
|
|
HOME
3268
DELISTED
At Home Group Inc.
HOME
| $19.4K | ﹤0.01% |
2,982
-13,040
| -81% | -$53.3K |
|
3269
electroCore
ECOR
$90.2M
| $19.3K | ﹤0.01% |
1,570
+1,305
| +492% | +$18.6K |
|
3270
Coda Octopus Group
CODA
$117M
| $19.3K | ﹤0.01% |
3,743
+2,166
| +137% | +$11.4K |
|
|
GPOR
3271
DELISTED
Gulfport Energy Corp.
GPOR
| $19.2K | ﹤0.01% |
17,623
-47,299
| -73% | -$70.6K |
|
|
CDMO
3272
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $19.1K | ﹤0.01% |
2,917
-14,413
| -83% | -$80.5K |
|
3273
Nicolet Bankshares
NIC
$3.76B
| $19.1K | ﹤0.01% |
349
-2,537
| -88% | -$137K |
|
3274
Clarus
CLAR
$141M
| $19.1K | ﹤0.01% |
1,654
-5,440
| -77% | -$55.2K |
|
|
ACRE
3275
Ares Commercial Real Estate
ACRE
$264M
| $19.1K | ﹤0.01% |
2,095
-8,258
| -80% | -$64.4K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.